Sonova stock gains as Morgan Stanley raises price target on AI hearing platform
Published on 09/03/2026 at 16:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sonova (ISIN CH0012549785) stock is trading higher, supported by a recent price-target increase and solid market data as of September 2, 2026, which show a closing level of 78.63 Swiss francs and a modest year-to-date decline of 1.55 percent according to MarketScreener.
Price-target boost underpins Sonova stock
According to an update on European medtech stocks by Morgan Stanley reported on September 3, 2026, and summarized by Investing.com, the bank raised its price target for Sonova stock to 245 Swiss francs from 205 Swiss francs, implying a potential upside of 83.25 percent relative to the recent closing price of 133.72 Swiss francs referenced in that analysis.
Separate market data compiled by Yahoo Finance and cited in an earlier Sonova-focused note show that an intraday quote of 238.40 Swiss francs reflected a gain of 4.40 Swiss francs or 1.88 percent compared to the previous close as of September 2, 2026, underscoring that Sonova stock has reacted positively to supportive analyst commentary and sector sentiment.
Latest market figures and Swiss listing context
For investors tracking the Swiss market backdrop, data from MarketScreener as of September 2, 2026, indicate that Sonova shares closed at 78.63 Swiss francs on the SIX Swiss Exchange, a level that sits 10.99 Swiss francs below the consensus price target of 88.36 Swiss francs cited in the same overview and corresponds to a short-term performance of plus 0.15 percent over the preceding five trading days.
The same MarketScreener snapshot highlights that Sonova stock has declined 1.55 percent since the start of 2026 while the Swiss market index environment remains mixed, giving investors a quantified picture of how the hearing-care specialist is tracking relative to domestic peers represented in the Swiss Market Index.
More on Sonova stock and fundamentals
Read further corporate and market news on Sonova and access its investor materials for a fuller view of earnings, guidance and segment performance.
Phonak EON AI hearing platform as growth driver
Beyond short-term price moves, Sonova’s strategic focus is increasingly on innovation in hearing technology, highlighted by its recent unveiling of the Phonak EON platform, an AI-powered hearing-aid solution presented as part of its growth strategy in a Reuters report updated August 24, 2026.
In that Reuters coverage, Sonova representatives emphasized that Phonak EON is designed to be smaller and lighter than previous devices while using artificial intelligence to improve speech clarity in challenging listening environments, positioning the product to capture demand in premium segments of the global hearing-instruments market.
Representative product and segment footprint
At the product level, Sonova is active across multiple brands and segments in hearing care, including Phonak in hearing instruments and AudioNova in audiological care services, as outlined in a company profile on Yahoo Finance updated on September 3, 2026.
The profile further explains that Sonova’s business spans Hearing Instruments, Cochlear Implants and Lifestyle-Aligned segments, covering wireless headsets, speech-enhanced hearables and audiophile headphones, which together broaden its revenue base beyond traditional hearing aids and provide diversified exposure to global consumer and medical markets.
Sonova stock price snapshot and investor view
As of the last completed trading session on September 2, 2026, Sonova stock closed at 78.63 Swiss francs on the SIX Swiss Exchange according to MarketScreener data, with the same source citing an average analyst price target of 88.36 Swiss francs that implies a consensus upside of 12.37 percent from that closing level.
Sonova stock at a glance
- Company: Sonova Holding AG
- ISIN: CH0012549785
- Ticker: SOON
- Trading venue: SIX Swiss Exchange
- Price (as of September 2, 2026): 78.63 CHF
- Market capitalization: 12,300,000,000 CHF (as of September 2, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: Swiss Market Index
